FDA Webview
X
about-us-banner

FDA Related News

Home / Articles / FDA Related News
Human Drugs

FDA Lab Findings Confirm Contaminated Docusate Sodium

FDA says its lab findings again link Rugby Dioctos oral liquid docusate sodium to Burkholderia cepacia.

FDA General

Latest Federal Register Notices

FDA Review posts the Federal Register notices for the week ending 10/27/2017.

Federal Register

Comments Sought on CVM Dispute Resolution Info Collection

Federal Register notice: FDA seeks comments on an information collection extension about a guidance on dispute resolution procedures for CVM regulator...

Federal Register

Draft Guide on Generic Drug User Fees

FDA releases a draft guidance on Assessing User Fees Under the Generic Drug User Fee Amendments of 2017.

Federal Register

FDA Draft Guide on Pediatric GERD Drug Development

Federal Register notice: FDA makes available a draft guidance entitled Pediatric Gastroesophageal Reflux Disease: Developing Drugs for Treatment.

Human Drugs

Priority Review for Abbvie Endometriosis Therapy

FDA accepts for priority review an AbbVie NDA for elagolix, an investigational, orally administered gonadotropin-releasing hormone antagonist for mana...

Medical Devices

FDA Clears Butterfly Network Ultrasound-on-a-Chip

FDA clears a Butterfly Network 510(k) for what the sponsor describes as the worlds first ultrasound-on-a-chip based imaging system, the Butterfly iQ f...

Medical Devices

Guidance for Using De Novo Classification Process

FDA posts a guidance on De Novo Classification Process (Evaluation of Automatic Class III Designation) that provides recommendation on how to use the ...

Medical Devices

Guide on Sharing Patient Info Collected on Medical Devices

FDA issues a final guidance document entitled Manufacturers Sharing Patient-Specific Information from Medical Devices with Patients upon Request.

Federal Register

Comments Sought on Dispute Resolution Guidance Extension

Federal Register: FDA seeks comments on an information collection extension related to a guidance on formal dispute resolution on drug GMP issues.